Regulation of orexin neurons by the monoaminergic and cholinergic systems

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 120-129

  Yamanaka, Akihiro ^a,b   Muraki, Yo ^a   Tsujino, Natsuko ^a,b   Goto, Katsutoshi ^a   Sakurai, Takeshi ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Acetylcholine; Action potential; Hyperpolarization activated current; Noradrenaline; Orexin; Patch clamp; Serotonin

Indexed keywords

CARBACHOL; NEUROTRANSMITTER; NORADRENALIN; OREXIN; SEROTONIN; TETRODOTOXIN; ACETYLCHOLINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CARRIER PROTEIN; GREEN FLUORESCENT PROTEIN; N METHYLASPARTIC ACID; NEUROPEPTIDE; OREXINS; PHOTOPROTEIN; SIGNAL PEPTIDE;

ADAPTATION; ALERTNESS; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ACTIVITY; CELL ASSAY; CELL NUCLEUS; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEPOLARIZATION; ELECTROPHYSIOLOGY; FEMALE; HYPERPOLARIZATION; MALE; MONOAMINERGIC SYSTEM; MOUSE; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; SLEEP WAKING CYCLE; TRANSGENIC MOUSE; ACTION POTENTIAL; ANIMAL; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM; PATCH CLAMP;

MUS MUSCULUS;

ACETYLCHOLINE; ACTION POTENTIALS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CARRIER PROTEINS; ELECTROPHYSIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUMINESCENT PROTEINS; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; N-METHYLASPARTATE; NEURONS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PATCH-CLAMP TECHNIQUES;

EID: 0037470734     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00299-7     Document Type: Article

References (37)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett II F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA. 95:1998;322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
3. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
4. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
5. Morgane P.J. Amine pathways and sleep regulation. Brain Res. Bull. 9:1982;743-749.
6. Saper C.B. Diffuse cortical projection systems: anatomical organization and role in cortical function. Plum F. Handbook of Physiology - The Nervous system. American Physiological Society. vol. 5:1987;169-210.
7. Delagrange P., Canu M.H., Rougeul A., Buser P., Bouyer J.J. Effects of locus coeruleus lesions on vigilance and attentive behaviour in cat. Behav. Brain. Res. 53:1993;155-165.
8. Liu R.J., van den Pol A.N., Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 22(21):2002;9453-9464.
9. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M., Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873:2000;181-187.
10. Brown R.E., Sergeeva O., Eriksson K.S., Haas H.L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology. 40:2001;457-459.
11. Brown R.E., Sergeeva O.A., Eriksson K.S., Haas H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 22:2002;8850-8859.
12. van den Pol A.N., Ghosh P.K., Liu R.J., Li Y., Aghajanian G.K., Gao X.B. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J. Physiol. 541:2002;169-185.
13. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.L., Wang Q.P., Tominaga M., Goto K., Shioda S., Sakurai T. Orexins activate histaminergic neurons via the orexin2 receptor. Biochem. Biophys. Res. Commun. 290:2002;1237-1245.
14. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., van den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. Proc. Natl. Acad. Sci. USA. 96(19):1999;10911-10916.
15. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21(23):2001;9273-9279.
16. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23(1):2003;7-11.
17. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
18. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
19. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30:2001;345-354.
20. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 355(9197):2000;39-40.
21. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6(9):2000;991-997.
22. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27(3):2000;469-474.
23. Sakurai T., Moriguchi T., Furuya K., Kajiwara N., Nakamura T., Yanagisawa M., Goto K. Structure and function of human prepro-orexin gene. J. Biol. Chem. 274:1999;17771-17776.
24. A. Yamanaka, C.T. Beuckmann, J.T. Willie, J. Hara, N. Tsujino, M. Mieda, M. Tominaga, K. Yagami, F. Sugiyama, K. Goto, M. Yanagisawa, T. Sakurai, Hypothalamic orexin neurons regulate arousal according to energy balance in mice, 2003 (submitted).
25. Lancaster B., Nicoll R.A. Properties of two calcium-activated hyperpolarizations in rat hippocampal neurons. J. Physiol. 389:1987;187-203.
26. Pape H.C. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu. Rev. Physiol. 58:1996;299-327.
27. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435(1):2001;6-25.
28. Takahashi K., Toyama Y., Kayama Y., Yamamoto M. Effects of orexin on the laterodorsal tegmental neurons. Psychiatry Clin. Neurosci. 56(3):2002;335-336.
29. Burlet S., Tyler C.J., Leonard C.S. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J. Neurosci. 22(7):2002;2862-2872.
30. Alam M.N., Gong H., Alam T., Jaganath R., McGinty D., Szymusiak R. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J. Physiol. 538:2002;619-631.
31. Kiyashchenko L.I., Mileykovskiy B.Y., Maidment N., Lam H.A., Wu M.F., John J., Peever J., Siegel J.M. Release of hypocretin (orexin) during waking and sleep states. J. Neurosci. 22(13):2002;5282-5286.
32. Ooi H., Colucci W.S. Pharmacological heart failure. Hardman J.G., Limbird L.E., Gilman A.G. The Pharmacological Basis of Therapeutics. 2001;901 McGraw-Hill, New York.
33. Miller J.D., Farber J., Gatz P., Roffwarg H., German D.C. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res. 273(1):1983;133-141.
34. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu. Rev. Physiol. 55:1993;455-472.
35. Robinson R.B., Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu. Rev. Physiol. 65:2003;453-480.
36. DiFrancesco D., Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature. 351:1991;145-147.
37. 2+ of the hyperpolarization-activated inward current in rabbit single sino-atrial node cells J. Physiol. 409:1989;121-141.